LP-284 targets DNA repair defects in cancers, showing promise in preclinical and early clinical trials across multiple cancer types. The FDA's orphan drug designation supports LP-284's development for ...
Third FDA orphan designation for LP-284; Sixth overall for Lantern’s A.I.-driven precision oncology pipeline Orphan designation expands LP-284's potential for an estimated ~96,000 global annual soft ...
— Daylen Lile hit an inside-the-park homer in the 11th inning that sent the Washington Nationals past the New York Mets 5-3 on Saturday. — Juan Soto hit a three-run homer during a six-run fourth ...
Highly potent but poorly water-soluble drug (PWSD) candidates are common outcomes of contemporary drug discovery programmes. These lipophilic compounds often exhibit poor systemic exposure following ...
Background There is increasing pressure to tackle the wider social determinants of health through the implementation of appropriate interventions. However, turning these demands for better evidence ...
This proceedings contains 89 papers from 25 countries and regions, including 14 keynote lectures and 17 invited lectures, presented at the Third International Conference on Geotechnical Engineering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results